NeoStem, Inc. 4
4 · NeoStem, Inc. · Filed May 21, 2015
Insider Transaction Report
Form 4
Preti Robert A
See Remarks
Transactions
- Award
Common stock, $0.001 par value
2015-05-19+520→ 190,954 total
Footnotes (1)
- [F1]Represents the Reporting Person's one third percentage of the contingent shares of common stock, par value $0.001 per share, of NeoStem, Inc. (the "Company"), which was issued in accordance with the terms of the Agreement and Plan of Merger, dated July 13, 2011, between the Company and Amorcyte, Inc. (the "Merger Agreement").